Steph Sisson is a commercialisation scientist and strategy leader currently overseeing the divestment of Callaghan Innovation’s pharmaceutical business. With a strong focus on translating complex R&D into clear commercial strategies, Steph has extensive experience in various sectors, including food, biotechnology, and health. They have previously held roles such as Innovation Manager at Cookie Time Group and Quality Assurance Manager at Waitaki Biosciences International Ltd., and they founded FoodDNA to assist regulated industries in bringing scientific innovations to market. Currently, Steph serves as an Associate Director at Deloitte, where they support New Zealand companies in navigating the R&D Tax Incentive.
This person is not in the org chart
This person is not in any teams
This person is not in any offices